WCP
AZN icon

Wick Capital Partners’s AstraZeneca AZN Stock Holding History

Wick Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,658
Closed -$721K – 252
2026
Q1 		$721K Buy
3,658
+45
+1% +$8.68K 0.13% 68
2025
Q4 		$664K Buy
3,613
+10
+0.3% +$1.75K 0.12% 71
2025
Q3 		$553K Sell
3,603
-7,387
-67% -$1.12M 0.13% 72
2025
Q2 		$503K Buy
10,990
+7,347
+202% +$1.03M 0.13% 70
2025
Q1 		$535K Sell
3,643
-343
-9% -$49.6K 0.16% 63
2024
Q4 		$522K Sell
3,986
-31
-0.8% -$4.34K 0.15% 61
2024
Q3 		$626K Hold
4,017
– – 0.2% 48
2024
Q2 		$626K Sell
4,017
-284
-7% -$42.7K 0.22% 44
2024
Q1 		$583K Hold
4,301
– – 0.57% 22
2023
Q4 		$579K Sell
4,301
-9
-0.2% -$1.17K 0.24% 38
2023
Q3 		$584K Sell
4,310
-8
-0.2% -$1.09K 0.33% 35
2023
Q2 		$618K Buy
4,318
+16
+0.4% +$2.35K 0.37% 27
2023
Q1 		$597K Sell
4,302
-90
-2% -$12.1K 0.34% 33
2022
Q4 		$595K Buy
4,392
+140
+3% +$17.6K 0.33% 31
2022
Q3 		$466K Sell
4,252
-191
-4% -$24.2K 0.3% 31
2022
Q2 		$587K Buy
+4,443
New +$583K 0.41% 23

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wick Capital Partners's AZN Position: Q2 2026 in Review

Wick Capital Partners sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 3,658 shares — an estimated $721K sold.

Wick Capital Partners first reported a position in AZN in Q2 2022 and held it in 16 quarters. The position peaked at $721K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Wick Capital Partners reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Wick Capital Partners sold 3,658 AstraZeneca shares in Q2 2026, an estimated $721K.
  • Wick Capital Partners first reported a position in AstraZeneca in Q2 2022 and held it in 16 quarters.
  • Wick Capital Partners's AstraZeneca position peaked at $721K in Q1 2026.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wick Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.